Literature DB >> 19847567

Positive peritoneal washing cytology in multiple cavities can predict poor prognosis of advanced gastric cancer patients.

Yoichiro Homma1, Shinichiro Ushida, Makoto Yamada, Hiroshi Kobayashi, Kazufumi Suzuki.   

Abstract

BACKGROUND: Positive peritoneal washing cytology (PWC) has been reported to be a poor prognostic factor for gastric cancer. Japanese gastric cancer classifications recommend PWC in Douglas' pouch for advanced gastric cancer. However, the sensitivity of PWC is relatively low. The goal of this study was to investigate whether PWC in multiple cavities increases its sensitivity to predict prognosis.
METHODS: Between January 1996 and December 2006, a series of 992 patients with gastric cancer underwent D2 gastrectomy with intraoperative PWC. Of the 992 patients, 62 patients had positive PWC. PWC was conducted in four cavities (left subphrenic cavity, right subhepatic cavity, Douglas' pouch, and inside the omental bursa). The 62 patients were retrospectively analyzed for their background and survival.
RESULTS: Eleven (17.7%) patients had negative PWC in Douglas' pouch but were positive in the other cavities. The 62 patients were classified into two groups according to the number of positive PWC cavities: 20 patients with one or two and 42 patients with three or four positive PWC cavities. No significant difference in clinicopathological features was observed between these two groups. However, the overall and progression-free survival rates of patients with one or two positive PWC cavities were significantly higher than those for patients with three or more positive PWC cavities.
CONCLUSION: PWC in multiple cavities was more sensitive than only in one cavity. The number of positive cavities may indicate the grade of tumor spread in the peritoneum and predict the prognosis of patients with positive PWC.

Entities:  

Mesh:

Year:  2009        PMID: 19847567     DOI: 10.1245/s10434-009-0764-2

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  13 in total

1.  Positive peritoneal washing cytology is a potential risk factor for the recurrence of curatively resected colorectal cancer.

Authors:  Yoichiro Homma; Takashi Hamano; Yasuhiro Akazawa; Yoshiro Otsuki; Shinichi Shimizu; Hiroshi Kobayashi; Shingo Kameoka; Yasuyuki Kobayashi
Journal:  Surg Today       Date:  2013-08-14       Impact factor: 2.549

2.  Very early-onset peritoneal recurrence following curative total gastrectomy for Borrmann 4 gastric cancer.

Authors:  Dong Jin Kim; Jun Hyun Lee; Wook Kim
Journal:  Ann Surg Treat Res       Date:  2014-01-01       Impact factor: 1.859

3.  The survival and prognosticators of peritoneal cytology-positive gastric cancer patients who received upfront gastrectomy and subsequent S-1 chemotherapy.

Authors:  Kazuki Kano; Toru Aoyama; Yukio Maezawa; Tetsushi Nakajima; Kosuke Ikeda; Takanobu Yamada; Tsutomu Sato; Takashi Oshima; Yasushi Rino; Munetaka Masuda; Takashi Ogata; Haruhiko Cho; Takaki Yoshikawa
Journal:  Int J Clin Oncol       Date:  2017-04-29       Impact factor: 3.402

4.  Prognostic factors of T4 gastric cancer patients undergoing potentially curative resection.

Authors:  Naoto Fukuda; Yasuyuki Sugiyama; Joji Wada
Journal:  World J Gastroenterol       Date:  2011-03-07       Impact factor: 5.742

5.  Intraoperative dissemination during gastrectomy for gastric cancer associated with serosal invasion.

Authors:  Yukio Tokumitsu; Shigefumi Yoshino; Michihisa Iida; Kiyoshi Yoshimura; Tomio Ueno; Shoichi Hazama; Masaaki Oka
Journal:  Surg Today       Date:  2014-08-14       Impact factor: 2.549

Review 6.  Advanced gastric cancer: What we know and what we still have to learn.

Authors:  Federico Coccolini; Giulia Montori; Marco Ceresoli; Simona Cima; Maria Carla Valli; Gabriela E Nita; Arianna Heyer; Fausto Catena; Luca Ansaloni
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

Review 7.  Detection value of free cancer cells in peritoneal washing in gastric cancer: a systematic review and meta-analysis.

Authors:  Francisco Tustumi; Wanderley Marques Bernardo; Andre Roncon Dias; Marcus Fernando Kodama Pertille Ramos; Ivan Cecconello; Bruno Zilberstein; Ulysses Ribeiro-Júnior
Journal:  Clinics (Sao Paulo)       Date:  2016-12-01       Impact factor: 2.365

Review 8.  Advanced gastric cancer: the value of systemic and intraperitoneal chemotherapy.

Authors:  Federico Coccolini; Paola Fugazzola; Luca Ansaloni; Massimo Sartelli; Enrico Cicuttin; Gioacchino Leandro; Gian Luigi De' Angelis; Federica Gaiani; Francesco Di Mario; Matteo Tomasoni; Fausto Catena
Journal:  Acta Biomed       Date:  2018-12-17

9.  Proposal of a New TNM Classification for Gastric Cancer: Focusing on pN3b and Cytology-Positive (CY1) Disease.

Authors:  Sa-Hong Kim; Hyuk-Joon Lee; Ji-Hyeon Park; Jong-Ho Choi; Shin-Hoo Park; Hwi-Nyeong Choe; Seung-Young Oh; Yun-Suhk Suh; Seong-Ho Kong; Do-Joong Park; Han-Kwang Yang
Journal:  J Gastric Cancer       Date:  2019-09-26       Impact factor: 3.720

10.  GASTRICHIP: D2 resection and hyperthermic intraperitoneal chemotherapy in locally advanced gastric carcinoma: a randomized and multicenter phase III study.

Authors:  Olivier Glehen; Guillaume Passot; Laurent Villeneuve; Delphine Vaudoyer; Sylvie Bin-Dorel; Gilles Boschetti; Eric Piaton; Alfredo Garofalo
Journal:  BMC Cancer       Date:  2014-03-14       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.